MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/ehjimp/qyaf047

Медицинская библиотека · European heart journal. Imaging methods and practice · 2025

Quantification of perivascular adipose tissue attenuation does not add incremental prognostic value in patients undergoing transcatheter aortic valve implantation.

Donà Carolina, Pavo Noemi, Vinzens Adriana, Gebert Pimrapat, Beitzke Dietrich, Reider Lukas, Mikail Nidaa, Rossi Alexia, Mascherbauer Katharina, Bengs Susan, Haider Achi, Buechel Ronny R, Bartko Philipp E, Loewe Christian, Mascherbauer Julia, Hengstenberg Christian, Goliasch Georg, Winter Max Paul, Gebhard Catherine

СтатьяПеревод пока не подготовлен

Аннотация

AIMS: Perivascular adipose tissue attenuation (PVAT) has emerged as a novel coronary computed tomography angiography (CCTA)-based biomarker predicting cardiovascular events by capturing inflammation around the coronary arteries. We assessed whether PVAT adds incremental prognostic value in patients undergoing transcatheter aortic valve implantation (TAVI).

METHODS AND

RESULTS

A total of 510 patients underwent CCTA imaging prior to TAVI between November 2015 and June 2020 at the Medical University of Vienna. PVAT was obtained from CCTA images and was measured around the right coronary artery [PVAT(RCA)] and the aortic valve [PVAT(valve)]. Following application of exclusion criteria, 372 patients [mean age 80.6 ± 6.8 years; 169 (45%) women] were analysed. Over a median follow-up of 3.0 (IQR 2.5-3.6) years, 52 (14%) individuals experienced a major adverse cardiovascular event (MACE, a composite of non-fatal stroke or myocardial infarction, cardiac death, or vascular intervention). Individuals exhibiting elevated PVAT[valve] displayed a heightened surgical risk according to European System for Cardiac Operative Risk Evaluation II, a lower body mass index, reduced left ventricular ejection fraction, prolonged hospitalization following TAVI, and elevated levels of circulating inflammatory markers compared with those in the low PVAT[valve] group (P < 0.05). However, neither PVAT[valve] nor PVAT[RCA] were independently associated with the occurrence of MACE in adjusted multi-variable analyses (PVAT[valve]: sub-distribution hazard ratio [SHR] 1.14, 95% CI:0.63-2.05, P = 0.672); PVAT[RCA]: SHR 1.16 [95% CI: 0.81-1.66], P = 0.417).

CONCLUSION

Measuring PVAT around either the right coronary artery or the aortic valve does not provide additional prognostic value beyond established risk factors for the prediction of MACE in patients undergoing TAVI.

Для цитирования: Donà Carolina, Pavo Noemi, Vinzens Adriana, Gebert Pimrapat, Beitzke Dietrich, Reider Lukas, Mikail Nidaa, Rossi Alexia, Mascherbauer Katharina, Bengs Susan, Haider Achi, Buechel Ronny R, Bartko Philipp E, Loewe Christian, Mascherbauer Julia, Hengstenberg Christian, Goliasch Georg, Winter Max Paul, Gebhard Catherine. Quantification of perivascular adipose tissue attenuation does not add incremental prognostic value in patients undergoing transcatheter aortic valve implantation.. European heart journal. Imaging methods and practice. 2025. DOI: 10.1093/ehjimp/qyaf047.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.